COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,141 Articles (22,693 medRxiv, 8,448 bioRxiv)

Most recent first Previous |  Page 247: Articles 2461-2470  | Next

RISK OF THROMBOEMBOLISM AFTER COVID-19 VACCINATION AND COVID-19 INFECTION.
Tran, H., Risk, M., Lee, Y.-C., Nair.B, G., Zhao, L.
10.1101/2024.02.12.24302535 — Posted: 2024-02-18
Increased reproductive tract infections among secondary school girls during the COVID-19 pandemic: associations with pandemic related stress, mental health, and domestic safety
Mehta, S. D., Nandi, D., Otieno, F., Zulaika, G., Nyothach, E., Agingu, W., Bhaumik, R., Mason, L., van Eijk, A. M., Phillips-Howard, P. A.
10.1101/2024.02.17.24302973 — Posted: 2024-02-18
Non-Consensual Sex among Japanese Women in the COVID-19 Pandemic: A Large-Scale Nationwide Survey-Based Study
Suzuki, T., Kaneda, Y., Kotera, Y., Tanimoto, T., Ozaki, A., Bhandari, D., Horiuchi, S., Tabuchi, T.
10.1101/2024.02.16.24302967 — Posted: 2024-02-18
SARS-CoV-2 infection and Pregnancy outcome: A cross-sectional study from Eastern U.P. Population, India
Rai, S., Ashish, A., Mishra, S., Kumar, B., Kusum, K., Singh, R.
10.1101/2024.02.15.24302882 — Posted: 2024-02-17
Effectiveness of Omicron XBB.1.5 vaccine against SARS-CoV-2 Omicron XBB and JN.1 infection in a prospective cohort study in the Netherlands, October 2023 to January 2024
Huiberts, A. J., Hoeve, C. E., de Gier, B., Cremer, J., van der Veer, B., de Melker, H. E., van de Wijgert, J. H. H. M., van den Hof, S., Eggink, D., Knol, M.
10.1101/2024.02.15.24302872 — Posted: 2024-02-17
An intersectional perspective on gender/sex disparities in the epidemiology of COVID-19 cascade from testing to mortality: Evidence from Swiss surveillance data
Auderset, D., Amiguet, M., Clair, C., Pittet, V., Riou, J., Schwarz, J., Mueller, Y.
10.1101/2024.02.16.24302879 — Posted: 2024-02-17
Barriers in accessing healthcare during the COVID-19 pandemic: analysis of the Virus Watch community cohort study
Menezes, D., Siegele-Brown, C., Yavlinsky, A., Nguyen, V., Braithwaite, I., Burns, R., Tweed, S., Oskrochi, Y., Kovar, J., Fong, W. L. E., Hayward, A., Aldridge, R. W.
10.1101/2024.02.15.24302762 — Posted: 2024-02-17
Impact of COVID-19 on Emergency Medical Services Utilization and Severity in the U.S. Upper Midwest
Boggust, B., McCoy, R., Shalom, M., Myers, L., Rogerson, C.
10.1101/2024.02.15.24302863 — Posted: 2024-02-17
A critical reexamination of recovered SARS-CoV-2 sequencing data
Debarre, F., Hensel, Z.
10.1101/2024.02.15.580500 — Posted: 2024-02-16
Robust Neutralization of SARS-CoV-2 Variants Including JN.1 and BA.2.87.1 by Trivalent XBB Vaccine-Induced Antibodies
Wang, X., Jiang, S., Ma, W., Li, C., Liu, C., Xie, F., Zhu, J., Zhan, Y., Jiang, S., Li, M., Zhang, Y., Wang, P.
10.1101/2024.02.16.580615 — Posted: 2024-02-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).